Liver Transplantation in Acute‐on‐Chronic Liver Failure Is a Wise Longterm Investment
Jonel Trebicka, Luca S. Belli – 13 October 2020
A Claims‐Based Frailty Risk Score Is Associated With Hospitalization for Acute‐on‐Chronic Liver Failure: But Is It Frailty?
Jeremy Louissaint, Elliot B. Tapper – 13 October 2020
Role of Autoimmunity in Patients Transplanted for Acute Liver Failure of Unknown Origin: A Clinical and Graft Biopsy Analysis
Keiichi Fujiwara, Shin Yasui, Takayuki Kondo, Osamu Yokosuka, Naoya Kato – 12 October 2020
Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential
Sara A. Brown, Manhal Izzy, Kymberly D. Watt – 12 October 2020
Letter to the Editor: Tackling NAFLD in Adolescent Polycystic Ovary Syndrome: Reducing Liver Fat to Mimic Weight Loss
Francis Zegher, Lourdes Ibáňez – 12 October 2020
Pure Laparoscopic Donor Hepatectomy: Slowly But Surely Reaching Standard Practice
Daniel Cherqui – 12 October 2020
The Farewell Symphony
Paul Martin – 11 October 2020
REPLY:
Kara Wegermann, Ayako Suzuki, Alisha M. Mavis, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan – 11 October 2020
Adherence to Ideal Cardiovascular Health Metrics Is Associated With Reduced Odds of Hepatic Steatosis
Leah R. DeCoste, Na Wang, Joseph N. Palmisano, Jean Mendez, Udo Hoffmann, Emelia J. Benjamin, Michelle T. Long – 10 October 2020 – The American Heart Association (AHA) introduced Life’s Simple 7 as a metric to define ideal cardiovascular health. We examined the association between cardiovascular health score (CHS) and prevalent nonalcoholic fatty liver disease (NAFLD) among Framingham Heart Study participants with varying genetic risk of NAFLD. Framingham Heart Study participants who underwent abdominal computed tomography scans were included (n = 2,773).
Improving Medication‐Related Outcomes in Chronic Liver Disease
Kelly L. Hayward, Rianne A. Weersink – 10 October 2020 – Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medication‐related problems (MRPs) have been associated with adverse patient outcomes, including hospitalization and mortality. Factors that can contribute to MRPs in people with CLD are variable and often entwined.